[Drug interactions with vitamin K antagonists].
D000700:Analgesics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D001572:Benzofurans / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004336:Drug Antagonism; D004347:Drug Interactions; D004357:Drug Synergism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000627:therapeutic use
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000970:Antineoplastic Agents; D001463:Barbiturates; D001572:Benzofurans; D003374:Coumarins; D004232:Diuretics; D007004:Hypoglycemic Agents; D008996:Monoamine Oxidase Inhibitors; D012459:Salicylates; D013256:Steroids; D013449:Sulfonamides; D014812:Vitamin K; D014859:Warfarin; D002994:Clofibrate; D013974:Thyroxine
Interactions médicamenteuses avec les antivitamines.